General Information
Revision date
2008-08-18
Product name
Streptavidin Rhodamine Conjugated
supplier name
Thermo Fisher Scientific
Manufacturer Name
Thermo Fisher Scientific
Icons in SDS
Company Information
company name
Thermo Fisher Scientific
Section 2
SECTION 2: Hazards identification
Directive 67/548/EEC: Physical state Solid. [Powder.] OSHAIHCS status + While this material is not considered hazardous by the
Potential Acute Health Effects
Inhalation Exposure to airborne concentrations above statutory or recommended exposure limits may cause irritation of the nose, throat and lungs. Ingestion + No known significant effects or critical hazards. Skin + No known significant effects or critical hazards. Eyes Exposure to airborne concentrations above statutory or recommended exposure limits may cause irritation of the eyes.
Potential chronic health
effects No known significant effects or critical hazards, Carcinogenicity » No known signifi icant effects ts or critical hazards. Mutagenicity + No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards, 8/18/2009. Wr Streptavidin Rhodamine Conjugated 2, Developmental effects + No known significant effects or critical hazards, Fertility affects - No known significant effects or critical hazards, Over-exposure signsisymptoms Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specttic data. Skin - No specific data, Eyes Adverse symptoms may include the following: inftation redness Medical conditions » None known, aggravated by over- exposure The substance is not classified as dangerous according to Directive 67/548/EEC and its amendments.
2.1 Classification of the substance or mixture
Not classified, See toxicological information (section 11}